{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-005018","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.411042+00:00","generated_at":"2026-05-16T02:53:51.349243+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nu Skin Q4 revenue $370.3M (-16.9% YoY); FY2025 EPS $3.18, adj. $1.27; Q1 2026 outlook weak","bullets":["Q4 2025 revenue $370.3M, down 16.9% YoY; EPS $0.29 vs $(0.73) prior year.","FY2025 revenue $1.49B (-14.3%); EPS $3.18 (incl. Mavely gain), adjusted EPS $1.27 vs $0.84 prior.","Q1 2026 guidance: revenue $320-340M, EPS $0.10-0.20; full year 2026 revenue $1.35-1.50B, EPS $0.80-1.20.","Customers 748,796 (-10%), paid affiliates 129,311 (-11%), sales leaders 30,045 (-19%).","Company anticipates return to revenue growth by year-end 2026; 20,000+ Prysm iO devices deployed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-005018","json":"https://secwatch.observer/filing/0001140361-26-005018.json","markdown":"https://secwatch.observer/filing/0001140361-26-005018.md","text":"https://secwatch.observer/filing/0001140361-26-005018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036126005018/0001140361-26-005018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036126005018/ef20065530_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:53:51.349243+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}